In contrast, some molecules and compounds negatively regulate cardiac hypertrophy by suppressing TLR4/MyD88 signaling, which includes protein molecules such as MD1 and anti-HSP70 antibody and compounds such as Ang II type 1 receptor (AT1-R) antagonist and liver × receptors agonist (135–138). Here, TLR4 is linked to cardiac hypertrophy.